Latest Spago Nanomedical News & Updates

See the latest news and media coverage for Spago Nanomedical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Spago Nanomedical

Clinical-stage nanomedicines company

spagonanomedical.se
Headquarters
Lund, Sweden
Founded year
2007
Company type
Public company
Number of employees
15–50
Industry
Pharmaceuticals

Last updated

Latest news about Spago Nanomedical

In short: Spago Nanomedical raised SEK 15 million through a rights issue and progressed its Tumorad-01 clinical trial toward phase IIa completion.

Company announcements

Spago Nanomedical

Spago Nanomedical resolves on a SEK 16 million rights issue

Proceeds will fund phase I completion and phase IIa preparation of Tumorad-01 study; major shareholders committed to about 64 percent of the issue.

Unlock all announcements with a

Media coverage

Affärsvärlden

Good backing in Spago's rights issue

Spago Nanomedical has released the information document for its rights issue of SEK 16.2 million. The Emissions Guide raises one positive and two negative flags.

Morningstar

Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)

This English version of the notice to the Annual General Meeting is for convenience only. The shareholders of Spago Nanomedical AB (publ), corporate registration number...

Unlock all articles with a

Never miss news about Spago Nanomedical

Track Spago Nanomedical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Spago Nanomedical competitors & trending companies

Browse news for competitors to Spago Nanomedical and other trending companies.